Sotigalimab (Anti-TNFRSF5 / CD40)
Sotigalimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody targeting CD40. It can be used for the research of metastatic pancreatic adenocarcinoma.MW :144.54 KD.
| Trivial name | APX005M |
| Catalog Number | A2635 |
| CAS# | 2305607-45-6 |
| Size | 1mg*5 |